Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44555
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeyrman, Bert-
dc.contributor.authorMeers, Stef-
dc.contributor.authorSid, Selim-
dc.contributor.authorPUT, Natalie-
dc.contributor.authorTheunissen , Koen-
dc.contributor.authorVan Eygen, Koen-
dc.contributor.authorDe Beule, Nathan-
dc.contributor.authorClauwaert, Maxime-
dc.contributor.authorMaes , Helena-
dc.contributor.authorSalembier, Alexander-
dc.contributor.authorLemmens , Jan-
dc.contributor.authorVan De Velde, Ann-
dc.contributor.authorSelleslag, Dominik-
dc.contributor.authorBouziotis, Jason-
dc.contributor.authorDe Becker, Ann-
dc.contributor.authorAnguille, Sebastien-
dc.date.accessioned2024-10-28T12:41:12Z-
dc.date.available2024-10-28T12:41:12Z-
dc.date.issued2024-
dc.date.submitted2024-10-23T13:31:40Z-
dc.identifier.citationeJHaem, 5 (5) , p. 1096 -1099-
dc.identifier.urihttp://hdl.handle.net/1942/44555-
dc.description.sponsorshipThe authors would like to acknowledge all local study coordinators and local pharmacies for their aid in gathering the data. Special thanks to Charlotte Tuerlinckx, study coordinator at Ziekenhuis Oost Limburg and to Erwin Janssen and Karen Cox, study coordinators at Ziekenhuis Network Antwerp for their practical support.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights2024 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.-
dc.titleReal-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives-
dc.typeJournal Contribution-
dc.identifier.epage1099-
dc.identifier.issue5-
dc.identifier.spage1096-
dc.identifier.volume5-
local.format.pages4-
local.bibliographicCitation.jcatA1-
dc.description.notesHeyrman, B (corresponding author), Ziekenhuis Netwerk Antwerpen, Dept Haematol, Lindendreef 1, B-2020 Antwerp, Belgium.-
dc.description.notesbert.heyrman@zna.be-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1002/jha2.1027-
dc.identifier.pmid39415916-
dc.identifier.isi001328749900001-
local.provider.typewosris-
local.description.affiliation[Heyrman, Bert] Ziekenhuis Netwerk Antwerpen, Dept Haematol, Lindendreef 1, B-2020 Antwerp, Belgium.-
local.description.affiliation[Meers, Stef] Algemeen Ziekenhuis Klina, Dept Haematol, Brasschaat, Belgium.-
local.description.affiliation[Sid, Selim] Ctr Hosp Reg Verviers, Dept Haematol, Verviers, Belgium.-
local.description.affiliation[Put, Natalie] Ziekenhuis Oost Limburg, Dept Haematol, Genk, Belgium.-
local.description.affiliation[Theunissen, Koen] Jessa Ziekenhuis, Dept Haematol, Hasselt, Belgium.-
local.description.affiliation[Van Eygen, Koen] Algemeen Ziekenhuis Groeninge, Dept Haematol, Kortrijk, Belgium.-
local.description.affiliation[De Beule, Nathan; De Becker, Ann] Univ Ziekenhuis Brussel, Dept Haematol, Jette, Belgium.-
local.description.affiliation[Clauwaert, Maxime] Algemeen Ziekenhuis Sint Lucas, Dept Haematol, Ghent, Belgium.-
local.description.affiliation[Maes, Helena] Imelda Ziekenhuis, Dept Haematol, Bonheiden, Belgium.-
local.description.affiliation[Salembier, Alexander] Algemeen Ziekenhuis Glorieux, Dept Haematol, Ronse, Belgium.-
local.description.affiliation[Lemmens, Jan] Gasthuiszusters Antwerpen, Dept Haematol, Antwerp, Belgium.-
local.description.affiliation[Van De Velde, Ann; Anguille, Sebastien] Univ Ziekenhuis Antwerpen, Dept Haematol, Edegem, Belgium.-
local.description.affiliation[Selleslag, Dominik] Algemeen Ziekenhuis St Jan, Dept Haematol, Brugge, Belgium.-
local.description.affiliation[Bouziotis, Jason] Univ Ziekenhuis Antwerpen, Clin Trial Ctr, Edegem, Belgium.-
local.uhasselt.internationalno-
item.contributorHeyrman, Bert-
item.contributorMeers, Stef-
item.contributorSid, Selim-
item.contributorPUT, Natalie-
item.contributorTheunissen , Koen-
item.contributorVan Eygen, Koen-
item.contributorDe Beule, Nathan-
item.contributorClauwaert, Maxime-
item.contributorMaes , Helena-
item.contributorSalembier, Alexander-
item.contributorLemmens , Jan-
item.contributorVan De Velde, Ann-
item.contributorSelleslag, Dominik-
item.contributorBouziotis, Jason-
item.contributorDe Becker, Ann-
item.contributorAnguille, Sebastien-
item.accessRightsOpen Access-
item.fullcitationHeyrman, Bert; Meers, Stef; Sid, Selim; PUT, Natalie; Theunissen , Koen; Van Eygen, Koen; De Beule, Nathan; Clauwaert, Maxime; Maes , Helena; Salembier, Alexander; Lemmens , Jan; Van De Velde, Ann; Selleslag, Dominik; Bouziotis, Jason; De Becker, Ann & Anguille, Sebastien (2024) Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives. In: eJHaem, 5 (5) , p. 1096 -1099.-
item.fulltextWith Fulltext-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.